Virology in General Practice: HIV, Hepatitis, and Respiratory Infections
Specialists at the 4th Brazilian Congress of General Medicine (AMB) identified general practitioners as the primary gateway for the early diagnosis and management of HIV, viral hepatitis, and respiratory infections. According to panel experts, early detection and antiretroviral or antiviral treatments can significantly extend patient life expectancy and prevent chronic disease progression.
How does HIV treatment affect aging and life expectancy?
Antiretroviral treatment reduces accelerated aging in people living with HIV, though it does not eliminate the process entirely, according to Dr. Ricardo Sobhie Diaz. He noted that viremia plays a critical role in the natural history of the infection.
Dr. Diaz explained that while clinicians expect CD4 levels to rise during treatment, they do not always return to normal if they were previously too low. This can lead to immunosenescence, which is the natural deterioration and restructuring of the immune system caused by aging.
Despite these challenges, Dr. Diaz stated that when the viral load becomes undetectable and CD4 levels increase, life expectancy may actually be higher than that of people without HIV.
What are the current advancements in viral hepatitis treatment?
Modern treatments for viral hepatitis no longer require biopsies, interferon, or prolonged therapies with heavy side effects, according to Dr. Dimas Carnaúba Jr. He described current non-invasive tests as a “new stethoscope” for the liver.
Dr. Carnaúba Jr. emphasized that early identification of hepatitis B and C is critical because millions of people live with these infections without a diagnosis. He warned that failure to prevent the progression to advanced chronic liver disease could cause life expectancy to drop from 12 years to just two years.
How do treatment windows impact respiratory viral infections?
Effective treatment for respiratory viral infections requires extremely rapid intervention, according to Dra. Nancy Cristina Belei. She stated that for treatment to be truly effective, patients would need to be seen in less than 24 hours, a timeframe she described as difficult to achieve in practice.
Dra. Belei presented seasonality data for SARS-CoV-2, influenza, and Respiratory Syncytial Virus (RSV) spanning 2021 to 2026. She noted that influenza transmission can still be reduced if therapeutic intervention occurs within 48 hours of contact with an infected person.
What may happen next in viral disease management?
The role of the general practitioner is likely to expand as a central component of public health strategies. Because some countries have already placed these physicians at the heart of hepatitis elimination efforts, other regions may adopt similar frameworks to increase detection rates.
Increased focus on virology within general medical training could lead to more frequent early screenings for HIV and hepatitis. This shift may result in a higher percentage of patients achieving undetectable viral loads or complete cures before chronic complications develop.
Frequently Asked Questions
Can people living with HIV have a normal life expectancy?
Yes. According to Dr. Ricardo Sobhie Diaz, if the viral load is undetectable and CD4 levels increase through treatment, life expectancy can be as high as, or even higher than, those without HIV.
What is the current success rate for curing Hepatitis C?
Dr. Dimas Carnaúba Jr. stated that the cure rate for hepatitis C is approximately 95%.
How quickly must influenza be treated to reduce transmission?
According to Dra. Nancy Cristina Belei, therapeutic intervention within 48 hours of contact with an infected person can reduce the transmission of the disease.
Do you believe primary care physicians should be the main coordinators for chronic viral disease management?